This compound is primarily utilized in the pharmaceutical industry as a key intermediate in the synthesis of various active pharmaceutical ingredients (APIs). Its structure, featuring a chiral center and specific halogen substitution, makes it valuable for developing drugs targeting neurological and psychiatric disorders. It is often employed in the production of selective serotonin reuptake inhibitors (SSRIs) and other compounds that modulate neurotransmitter activity. Additionally, its unique chemical properties enable its use in asymmetric synthesis, contributing to the creation of enantiomerically pure drugs, which are critical for enhancing therapeutic efficacy and reducing side effects.